Oncopeptides is a pharmaceutical company that develops and commercializes therapies for the treatment of hematological cancer.
Read moreAnnual Revenue
$13.1M
Oncopeptides's revenue is the ranked 7th among it's top 10 competitors. The top 10 competitors average 10.2B. Over the last three quarters, Oncopeptides's revenue has grown by 179.1%. Specifically, in Q3 2021's revenue was $6.2M; in Q2 2021, it was $7.8M; in Q1 2021, it was $2.2M.